Singapore markets closed

Augmedix, Inc. (AUGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7765-0.0245 (-3.06%)
At close: 04:00PM EDT
0.7747 -0.00 (-0.23%)
After hours: 07:33PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 38.02M
Enterprise value 26.41M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.76
Price/book (mrq)2.14
Enterprise value/revenue 0.54
Enterprise value/EBITDA -2.38

Trading information

Stock price history

Beta (5Y monthly) -0.22
52-week change 3-82.92%
S&P500 52-week change 323.76%
52-week high 36.2500
52-week low 30.7300
50-day moving average 32.1224
200-day moving average 34.1817

Share statistics

Avg vol (3-month) 3720.04k
Avg vol (10-day) 3412.73k
Shares outstanding 548.97M
Implied shares outstanding 648.97M
Float 831.03M
% held by insiders 16.30%
% held by institutions 186.98%
Shares short (15 May 2024) 41.76M
Short ratio (15 May 2024) 41.67
Short % of float (15 May 2024) 46.69%
Short % of shares outstanding (15 May 2024) 43.59%
Shares short (prior month 15 Apr 2024) 41.24M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -41.95%
Operating margin (ttm)-47.52%

Management effectiveness

Return on assets (ttm)-27.11%
Return on equity (ttm)-280.05%

Income statement

Revenue (ttm)48.7M
Revenue per share (ttm)1.02
Quarterly revenue growth (yoy)39.90%
Gross profit (ttm)N/A
EBITDA -18.83M
Net income avi to common (ttm)-20.43M
Diluted EPS (ttm)-0.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)37.3M
Total cash per share (mrq)0.76
Total debt (mrq)25.69M
Total debt/equity (mrq)144.50%
Current ratio (mrq)2.04
Book value per share (mrq)0.37

Cash flow statement

Operating cash flow (ttm)-17.46M
Levered free cash flow (ttm)-15.49M